The typical American woman spends approximately one third of her lifetime in the postmenopausal state. As the population ages, physicians are called upon increasingly to help women adjust to their postmenopausal physiology. Participants in prior educational activities have requested discussions of the physiology and pharmacotherapeutics of postmenopausal hormone therapy.
The webcast should be useful for all healthcare providers who are concerned about postmenopausal hormone therapy and how to discuss treatment options with their patients. Healthcare providers should become aware of the risks and benefits of the various preparations available. This activity is intended to meet the critical need of identifying symptoms that require treatment and discussing appropriate treatment options to provide optimal patient care.
At the conclusion of this symposium, participants should be able to:
•Discuss the appropriate use of peri- and postmenopausal HT in symptomatic women.
•Counsel possible users of menopausal HT about associated risks and benefits.
•Develop appropriate treatment regimens for asymptomatic women who decide to use HT.
Slides/Transcript
CME Posttest and Evaluation
1.5 CME credits available
Click here
All speakers were required to complete a disclosure of commercial and financial relationships with manufacturers of pharmaceuticals, laboratory supplies, or medical devices and with commercial providers of medically related services. These disclosures were reviewed and potential conflicts of interest resolved by the Subcommittee on Standards of Commercial Support of the Continuing Medical Education Committee of the American Society for Reproductive Medicine. The disclosures are listed in the presentations.
Supported by an educational grant from Solvay Pharmaceuticals.
|
